Frost and Sullivan has presented bioMérieux with the 2006 Award for Market Leadership for its VITEK® 2 and VITEK® 2 Compact infectious disease antibiotic susceptibility testing (ID/AST) platforms. bioMérieux, a leading international company specializing in the field of in vitro diagnostics, has been selected for the award based on its overall excellence in the market leadership process.
“bioMérieux is very pleased to receive such a distinctive award,” says Eric Bouvier, bioMérieux’s North American president and CEO. “The market leadership award encompasses everything bioMérieux strives to deliver to the diagnostics industry.”
bioMérieux’s competitive market share, revenue growth rate, profitability, and innovative technology make them the recipient of this year’s Frost & Sullivan Market Leadership Award.
In the microbiological laboratory, bioMérieux has introduced high quality media and consumables, ID/AST, data analysis, and advice that improve turnaround time and are updated to respond to new antibiotics.